How to strengthen European industries’ leadership in vaccine research and innovation.
While EU countries have been able to rely on a more resilient social model and a science-based approach in managing the Covid crisis more successfully so far than the US, Europe has fallen short in matching the US effort to incentivise Covid vaccine innovation. This is due to a lower level of financial investment and . Read more…
Latest News
The Dynamic Effects of Mergers: a European Commission Study Prepared by Oxera
9 September 2026Friday, 11 September 2026 | 08:30–13:30, followed by lunchSolvay Brussels School of Economics and Management – Université libre de Bruxelles ECARES is pleased to host the economic workshop “The Dynamic Effects of Mergers: a European Commission Study Prepared by Oxera”, taking place at ULB on Friday, 11 September 2026. The workshop will present and discuss …
Continue reading "The Dynamic Effects of Mergers: a European Commission Study Prepared by Oxera"
Economic Workshop on the Dynamic Effects of Mergers
1 September 2026Friday, 11 September 2026 | 08:30–13:30, followed by lunchSolvay Brussels School of Economics and Management, Université libre de Bruxelles ECARES and the Solvay Brussels School of Economics and Management are pleased to host an economic workshop dedicated to “The Dynamic Effects of Mergers”, organised in connection with the Economic Study prepared by Oxera for the …
Continue reading "Economic Workshop on the Dynamic Effects of Mergers"
Paula Gobbi receives the 2026 EEA Role Models in Economics Award
Congratulations to Professor Paula Gobbi, Director of ECARES, who has received the prestigious 2026 EEA Role Models in Economics Award from the European Economic Association.
Visit us
ECARES - Solvay Brussels School of Economics and Management
Ave. F.D Roosevelt 42, 5th and 6th floors
1050 - Brussels - Belgium